Hepatocyte scaffold is an essential part in bioartificial liver device. We have designed a novel hepatocyte scaffold based on porcine liver extracellular matrix (ECM) and chitosan (CTS) fabrics. This CTS-ECM scaffold can improve cell adhesion and proliferation. In the present study, an orthogonal test was designed to optimize the CTS/ECM composite scaffold, in which ECM concentration, EDC concentration and EDC to NHS ratio were taken as factors, proportion of nitrogen element and hydroxyproline content as indicators. The cytocompatibility of the novel scaffold for C3A hepatocytes was analyzed in vitro. The orthogonal test demonstrated that the optimal scaffold should be based on ECM concentration of 5 mg/mL, EDC concentration of 5 mg/mL, and EDC to NHS ratio 1:1. C3A hepatocytes cultured on the optimized CTS-ECM scaffolds showed stronger proliferation and functionality than those on Cytodex3 microcarriers (p < 0.05). The CTS/ECM composite scaffold may be widely used as a promising hepatocyte culture carrier, especially in bioartificial liver support systems.
WengJHanXZengF, et al.Fiber scaffold bioartificial liver therapy relieves acute liver failure and extrahepatic organ injury in pigs. Theranostics2021; 11: 7620–7639.
2.
FujiiYHigashiKMizumotoH, et al.A bioartificial liver device based on three-dimensional culture of genetically engineered hepatoma cells using hollow fibers. Cytotechnology2020; 72: 227–237.
3.
Yu-Ting HeY-NQZhangB-QZhangBQ, et al.Bioartificial liver support systems for acute liver failure: a systematic review and meta-analysis of the clinical and preclinical literature. World J Gastroentero2019; 25: 3634–3648.
4.
ChenHSDongJooJShaheenM, et al.Randomized trial of spheroid reservoir bioartificial liver in porcine model of posthepatectomy liver failure. Hepatology2019; 69: 329–342.
5.
PuleriDFRoychowdhurySAmesJ, et al.Computational framework to evaluate the hydrodynamics of cell scaffold geometries. Annu Int Conf IEEE Eng Med Biol Soc2020; 2020: 2299–2302.
6.
O’BrienFJ. Biomaterials & scaffolds for tissue engineering. Mater Today2011; 14: 88–95.
7.
JainEDamaniaAKumarA, et al.Biomaterials for liver tissue engineering. Hepatol Int2014; 8: 185–197.
8.
JainSAhmad YassinMFuocoT, et al.Engineering 3D degradable, pliable scaffolds toward adipose tissue regeneration; optimized printability, simulations and surface modification. J Tissue Eng2020; 11: 1–17.
9.
PanZXiangLQinF, et al.Surface modification of small intestine submucosa in tissue engineering. Regen Biomater2020; 7: 339–348.
10.
MaZMaoZGaoC, et al.Surface modification and property analysis of biomedical polymers used for tissue engineering. Colloids Surf B Biointerfaces2007; 60: 137–157.
11.
MeldalMSchoffelenS. Recent advances in covalent, site-specific protein immobilization. F1000Res2016; 5: 2303.
12.
Nihal GevrekTDegirmenciASanyalR, et al.Multifunctional and transformable ‘clickable’ hydrogel coatings on titanium surfaces: from protein immobilization to cellular attachment. Polymers2020; 12: 1211.
13.
PengGLiSPengQ, et al.Immobilization of native type I collagen on polypropylene fabrics as a substrate for HepG2 cell culture. J Biomater Appl2017; 32: 93–103.
14.
ParkBParkSMLeeK, et al.Collagen immobilization on ultra-thin nanofiber membrane to promote in vitro endothelial monolayer formation. J Tissue Eng2019; 10: 1–12.
15.
ConfederatLGGabriela TuchilusCDraganM, et al.Preparation and antimicrobial activity of chitosan and its derivatives: a concise review. Molecules2021; 26: 3694.
16.
GonçalvesCFerreiraNLourençoL, et al.Production of low molecular weight chitosan and chitooligosaccharides (COS): a review. Polymers2021; 13: 2466.
17.
ZhaoCYangLPengG, et al.Decellularized liver matrix-modified chitosan fibrous scaffold as a substrate for C3A hepatocyte culture. J Biomater Sci Polym Ed2020; 31: 1041–1056.
18.
LonekerAEFaulkDMHusseyGS, et al.Solubilized liver extracellular matrix maintains primary rat hepatocyte phenotype in-vitro. J Biomed Mater Res A2016; 104: 957–965.
19.
ChenTXieLWangC, et al.Orthogonal test design for the optimization of superparamagnetic chitosan plasmid gelatin microspheres that promote vascularization of artificial bone. J Biomed Mater Res B Appl Biomater2020; 108: 1439–1449.
20.
MuşatVMaria AnghelEZahariaA, et al.A chitosan–agarose polysaccharide-based hydrogel for biomimetic remineralization of dental enamel. Biomolecules2021; 11: 1137.
21.
GuibalE.Milot aC.EterradossiO., et al.Study of molybdate ion sorption on chitosan gel beads by different spectrometric analyses. Int J Biol Macromol1999; 24: 49–59.
22.
KamarulTKrishnamurithyG.SalihND, et al.Biocompatibility and toxicity of poly(vinyl alcohol)/N, O-carboxymethyl chitosan scaffold. Scientific World Journal2014; 2014: 905103.
23.
PangYAnQLinX, et al.Biodegradable and biocompatible high elastic chitosan scaffold is cell-friendly both in vitro and in vivo. Oncotarget2017; 8: 35583–35591.
24.
BadylakSFTaylorDUygunK, et al.Whole-organ tissue engineering: decellularization and recellularization of threedimensional matrix scaffolds. Annu Rev Biomed Eng2011; 13: 27–53.
25.
Martinez-HernandezAAmentaPS. The extracellular matrix in hepatic regeneration. FASEB J1995; 9: 1401–1410.
26.
MoonJJWestJL. Vascularization of engineered tissues: approaches to promote angio-genesis in biomaterials. Curr Top Med Chem2008; 8: 300–310.
27.
MikiTRingAGerlachJ, et al.Hepatic differentiation of human embryonic stem cells is promoted by three-dimen sional dynamic perfusion culture conditions. Tissue Eng C Methods2011; 17: 557–568.
LinHYangGTanJ, et al.Influence of decellularized matrix derived from human mesenchymal stem cells on their proliferation, migration and multi-lineage differentiation potential. Biomaterials2012; 33: 4480–4489.
30.
HermansonGreg T. Bioconjugate Techniques. 3rd ed.Rockford, IL, USA: Thermo Fisher Scientific, 2013, p. 263.
31.
GacesaP.WhishWJ. The immobilization of adenine nucleotides on polysaccharides by using glutaraldehyde coupling and borohydride reduction. Biochem J1978; 175: 349–352.
32.
HardyPMNichollsACRydonHN, et al.The nature of the cross-linking of proteins by glutaraldehyde. Interaction of glutaraldehyde with the amino-groups of 6-ami-nohexanoic acid and of b-N-acetyl-lysine. J Chem Soc Perkin1976; 19: 958–962.
33.
GhoshSSKaoPMMcCueAW, et al.Use of maleimide-thiol coupling chemistry for efficient syntheses of oligonucleotide–enzyme conjugate hybridization probes. Bioconjug Chem1990; 1: 71–76.
34.
BonfieldTLJohnNBarnaBP, et al.Multiplexed particle-based anti-granulocyte macrophage colony stimulating factor assay used as pulmonary diagnostic test. Clin Diagn Lab Immunol2005; 12: 821–824.
35.
WangCYanQLiuHB, et al.Different EDC/NHS activation mechanisms between PAA and PMAA brushes and the following amidation reactions. Langmuir2011; 27: 12058–12068.
36.
PrabhawathiVBoobalanTSivakumarPM, et al.Functionalized polycaprolactam as an active food package for antibiofilm activity and extended shelf life. Colloids Surf B Biointerfaces2014; 123: 461–468.
37.
MaTLiYYangST. Tissue engineering human placenta trophoblast cells in 3-D fibrous matrix: spatial effects on cell proliferation and function. Biotechnol Prog1999; 15: 715–724.
RachmielDAnconinaIRudnick-GlickS, et al.Hyaluronic acid and a short peptide improve the performance of a pcl electrospun fibrous scaffold designed for bone tissue engineering applications. Int J Mol Sci2021; 22: 2425.
40.
LiYanKnissDouglas A.LaskyLarry C., et al.Culturing and differentiation of murine embryonic stem cells in a three-dimensional fibrous matrix. Cytotechnology2003; 41: 23–35.
41.
BuikemaJWLeeSGoodyerWR, et al.Activation and reduced cell-cell contact synergistically induce massive expansion of functional human iPSC-derived cardiomyocytes. Cell Stem Cell2020; 27: 50–63.
42.
BrennerJHülserDieter F. Production of tissue plasminogen activator (tPA) in two and three-dimensionally growing cultures of bowes melanoma cells. Biotechnol Bioeng1996; 51: 422–433.
